Abstract-It has not been examined whether the pressure-natriuresis response is altered in the insulin-resistant condition.
A growing body of evidence has been accumulated demonstrating that insulin resistance is an important risk factor to the development of cardiovascular diseases, including hypertension. [1] [2] [3] Although the pathophysiology of hypertension in insulin resistance remains fully undetermined, several investigations suggest that the kidney plays an important role in the development of hypertension. 4 Thus renal sodium homeostatic mechanisms are reported to be impaired in obesity, in which insulin resistance conceivably develops. 5 Furthermore, we have recently demonstrated that the pressure-natriuresis relation is impaired in Wistar fatty rats, manifesting obesity, hyperinsulinemia, and hyperglycemia. 6 Thus balanced sodium homeostasis is attained only at a higher renal perfusion pressure (RPP) in these obese rats than in normal littermates. The altered relation between RPP and renal sodium excretion is characteristic of several models of experimental hypertension, including spontaneously hypertensive rats and Dahl salt-sensitive rats 7, 8 and is generally accepted to be responsible for the development of hypertension in these rats. In Wistar fatty rats, however, hyperglycemia may also modify the renal sodium excretory function 6 and may thus confound the renal effect of insulin resistance per se. The relation between pressure-natriuresis and insulin sensitivity therefore has not been delineated.
Recently, much attention has been focussed on the mechanisms of pressure-natriuresis. Several investigations have been conducted examining the role of nitric oxide (NO) in pressure-natriuresis in hypertensive animals. 7, 9 The infusion of nitro-L-arginine methylester into the renal medulla markedly blunted pressure-natriuresis. 10 Furthermore, L-arginine corrected the impaired pressure-natriuresis when administered in hypertensive animals. 9 These studies suggest an important role of NO in the pressure-natriuresis response, and impaired sodium excretion is closely associated with altered NO activity within the medulla in hypertensive animals. Nevertheless, no investigations have been performed to clarify the effect of insulin resistance on renal interstitial NO release in obese animals.
In the present study, we investigated whether pressurenatriuresis was altered in insulin-resistant obese Zucker rats (OZ). Furthermore, the role of renal medullary and cortical interstitial NO in mediating pressure-natriuresis was assessed by evaluating the renal interstitial nitrate/nitrite (NOx) concentrations in these rats. Finally, to elucidate whether the correction of insulin resistance altered pressure-natriuresis, the effect of troglitazone, a novel thiazolidine-type insulinsensitizing agent, 11 on pressure-natriuresis response was examined.
Methods

Animals
All experimental protocols were conducted according to the guidelines of the Animal Care Committee of Keio University. Eighteen 4-week-old male OZ rats and their controls (lean Zucker, LZ) were used. The rats were divided into the following groups; (1) LZ (nϭ9); (2) LZϩtroglitazone (nϭ9); (3) OZ (nϭ9); and (4) OZϩtroglitazone (nϭ9). They were all prohibited from feeding 12 hours before the surgical preparation. They were placed in metabolic cages and were fed a standard rat chow (15 g/d, 0.38% Na, 0.97% K, 25.1% protein; Nippon Clea) with or without troglitazone (30 mg/d) for 4 weeks.
Pressure-Natriuresis
Animal preparation was performed as detailed previously. 6 -10 In brief, the right kidney and the right adrenal gland were removed 7 days before the experiment. For renal perfusion study, animals were anesthetized with sodium pentobarbital (50 mg/kg IP, Abbott) and tracheostomized to facilitate respiration. The left carotid and femoral arteries were cannulated (PE50, Becton Dickinson Co) to measure arterial blood pressure (BP) with the use of a pressure transducer (TP400T, Nihon Koden). The left external jugular vein was cannulated (PE50) for the infusion of saline containing a hormone cocktail described previously. 6 -10 With laparotomy, the left adrenal gland was removed and the left kidney was denervated with a 10% phenol solution in ethanol. An additional cannula (PE10) was placed in the left ureter for the collection of urine.
An adjustable clamp was placed on the aorta below left renal artery. Silk ligatures were placed loosely around the superior mesenteric and celiac arteries. RPP was altered by adjusting the resistance of these vessel segments.
Microdialysis
For determination of renal interstitial NOx concentrations, we used a renal microdialysis technique. 12, 13 This method has been reported to detect angiotensin-converting enzyme inhibitor-induced increases in medullary and cortical NOx contents. 13 A microdialysis tube (0.5-mm diameter and 10-kDa transmembrane diffusion cutoff; Eicom) was inserted into the cortex and medulla at a depth of 1 mm and 5 mm, respectively, from the renal surface. The microdialysis tube was perfused with lactated Ringer's solution (147 mEq/L Na, 4 mEq/L K, 5 mEq/L Ca, 156 mEq/L Cl) at 2 L/min. At this rate, in vitro recovery was 78Ϯ3% for nitrite and 70Ϯ4% for nitrate. A 120-minute stabilization period was allowed before the experiments. The effluent was stored at Ϫ20°C until NOx measurements by Griess reaction. 14 
Experimental Protocols
After a 120-minute equilibration period, the baseline BP was measured. Urine was collected during two 25-minute periods to measure urinary excretions of sodium, inulin, and paraaminohippuric acid (PAH). Then, the mesenteric and celiac arteries were occluded to increase RPP. After 15 minutes, two 25-minute renal clearance studies were conducted. Thereafter, RPP was further elevated by tightening the clamp below renal artery. At the midpoint of 2 clearance periods at each RPP, 1 mL of arterial blood was drawn, and an equal volume of blood from the similarly treated littermate was replaced. Values obtained from the 2 clearance periods were averaged.
Sodium concentrations were measured with a flame photometer. Inulin and PAH concentrations were measured by standard photometry. Glomerular filtration rate (GFR) and renal plasma flow (RPF) were calculated as the ratio of the urine per plasma concentration of inulin and PAH multiplied by urine flow rate.
Statistics
Results are expressed as meanϮSEM. Statistical analysis was evaluated by 2-way ANOVA, followed by multiple comparison post hoc test. A value of PϽ0.05 was considered statistically significant.
Results
Body Weight, BP, and Laboratory Data
Body weight and serum glucose concentration did not differ among the groups (Table 1) . OZ rats manifested elevated concentrations of serum insulin (PϽ0.01) and serum insulinto-glucose ratio (PϽ0.05), a marker of insulin resistance. 15 These elevated levels were markedly decreased by the treatment with troglitazone to those observed in LZ with or without troglitazone.
The basal BP in OZ rats (119Ϯ3 mm Hg, nϭ9) was higher than that in LZ rats (103Ϯ4 mm Hg, nϭ9, PϽ0.01) ( Table 1 ). The treatment with troglitazone reduced the BP in OZ [OZϩtroglitazone, 106Ϯ2 mm Hg (PϽ0.05, nϭ9) vs OZ] but had no effect on the BP in LZ (LZϩtroglitazone, 99Ϯ5 mm Hg, nϭ9).
Renal Function and Pressure-Natriuresis
Basal GFR or RPF did not differ among groups (Table 2) . In all groups, GFR was maintained constant during alterations in RPP. In response to elevated RPP, RPF increased in OZ (from 1.94Ϯ0.07 to 2.25Ϯ0.05 mL/min per gram of kidney weight, PϽ0.01) but was not altered in LZ, LZϩtroglitazone, or OZϩtroglitazone.
Elevated RPP markedly increased urine flow by 226Ϯ32% in LZ and by 196Ϯ37% in LZϩtroglitazone. In OZ, incre- ments in urine flow were diminished (123Ϯ10%, PϽ0.01), and troglitazone partially improved the pressure-induced increases in urine flow (178Ϯ7%). Figure 1 illustrates the pressure-natriuresis relation in Zucker rats. When RPP was elevated from baseline pressure to the maximal RPP examined, sodium excretion was prominently increased by 238Ϯ41% in LZ (from 3.06Ϯ0.65 to 11.17Ϯ2.14 Eq/min per gram of kidney weight/mm Hg, PϽ0.01) and by 266Ϯ52% in LZϩtroglitazone (from 3.34Ϯ0.51 to 12.03Ϯ1.75 Eq/min per gram of kidney weight/mm Hg, PϽ0.01); no difference was noted between LZ and LZϩtroglitazone. In contrast, the pressure-natriuretic response was markedly blunted in OZ and troglitazonetreated OZ, with only 103Ϯ36% (from 2.85Ϯ0.47 to 5.89Ϯ1.14 Eq/min per gram of kidney weight, PϽ0.01) and 173Ϯ18% increments in sodium excretion (from 3.11Ϯ0.62 to 8.42Ϯ0.70 Eq/min per gram of kidney weight, PϽ0.01), respectively.
The slope of the relations between RPP and urinary sodium excretion was significantly less in OZ than in LZ (OZ, 0.073Ϯ0.015 vs LZ, 0.241Ϯ0.015 Eq/min per gram of kidney weight/mm Hg, PϽ0.05). The treatment with troglitazone had no effect on the slope in LZ (LZϩtroglitazone; 0.217Ϯ0.047 Eq/min per gram of kidney weight/mm Hg, PϾ0.05 vs LZ). In troglitazonetreated OZ, the slope of the pressure-natriuresis (0.113Ϯ0.008 Eq/min per gram of kidney weight/ mm Hg) did not differ from that in OZ, but the pressurenatriuresis curve was shifted to lower RPP.
Renal Cortical and Medullary NOx Levels
The renal cortical NOx levels at the baseline RPP were markedly diminished in OZ rats (4.032Ϯ0.331 mol/L, nϭ7) compared with those in LZ (7.315Ϯ1.102 mol/L, PϽ0.01, nϭ7) (Figure 2 ). Treatment with troglitazone restored, albeit partially, the cortical NOx levels (ie, OZϩtroglitazone; 5.639Ϯ0.286 mol/L, nϭ7, PϽ0.01) in OZ rats, whereas no additional effect was observed in LZ. Elevating RPP had no effect on cortical NOx contents in either group of rats.
Similarly, basal medullary NOx levels in OZ rats were decreased 
Discussion
A large number of investigations suggest that insulin resistance causes systemic hypertension. [1] [2] [3] Although several lines Relations between renal perfusion pressure and sodium excretion. When compared with that in lean Zucker rats (E, nϭ7), obese Zucker rats manifested markedly impaired pressure-natriuresis response (Ⅺ, nϭ7). This blunted response was partially restored by troglitazone in obese Zucker rats (f, nϭ7), whereas no effect was observed in lean Zucker rats (F, nϭ7). Results are meanϮSEM. *PϽ0.05 vs baseline, **PϽ0.01 vs baseline.
of investigations have reported that the kidney is responsible for the development of hypertension in the insulin-resistant condition, 16 the precise mechanisms of insulin resistanceassociated hypertension remain undetermined. Recently, NO has been established to participate importantly in the control of renal function as a factor determining both microvascular tone and tubular function, and the derangement of NO production/action has been proposed as a contributory factor to the development of hypertension in several forms of hypertension. 7, 8 It has not been examined, however, whether insulin resistance alters the pressure-natriuresis response. Furthermore, the role of intrarenal NO in pressure-natriuresis has not been assessed in insulin resistance. The present study has demonstrated that OZ rats manifest not only metabolic abnormality associated with insulin resistance but also hemodynamic derangement, including systemic hypertension and impaired pressure-natriuresis. Furthermore, these alterations were reversed by troglitazone. Since the ratio of serum insulin to glucose, a marker of insulin sensitivity, 15 parallels the systemic and renal hemodynamic changes in OZ rats, it reasonably can be speculated that these alterations are a consequence of impaired insulin sensitivity in this rat strain. Although the blood glucose levels appear higher in all groups of rats, an infusion of a hormone cocktail including catecholamine 6 -10 may acutely affect the blood glucose and its response to troglitazone. Of note, we previously found impaired pressure-natriuresis responses in Wistar fatty rats. 6 These rats, however, manifested marked hyperglycemia and glucosuria, which may cause osmotic diuresis and thus affect tubular sodium excretion. The present observation that OZ and LZ rats exhibit similar blood glucose levels rather favors the possibility that insulin resistance per se participates importantly in abnormal pressure-natriuresis and hypertension and is in good accordance with the formulation that insulin resistance is importantly associated with systemic hypertension. 17, 18 A recent report by Abe et al 19 demonstrating the development of insulin resistance and hypertension in insulin receptor substrate-1-deficient mice is also consistent with this formulation.
Traditionally, obesity is reported to exhibit salt-sensitive hypertension. It remains a matter of controversy, however, how insulin resistance is associated with impaired natriuresis. 5, 16 In the present study, we have demonstrated the impaired pressure-natriuresis in OZ rats. Thus the slope of the pressure-natriuresis curve is diminished, a finding similar to that in other hypertensive animals, including Dahl salt-sensitive rats, 8 in which impaired pressurenatriuresis plays a crucial role in initiating or maintaining hypertension. In this regard, Kimura et al 20 found that the blunted slope of the pressure-natriuresis curve was associated with the impaired tubular sodium excretion or the decreased glomerular filtration coefficient. It is anticipated therefore that OZ rats manifest salt sensitivity and subsequent hypertension. Furthermore, the blunted pressurenatriuresis in OZ rats despite nearly the same GFR in OZ and LZ rats should be attributed to the altered tubular sodium handling. Of note, it has recently been reported that OZ rats possess a fa/fa gene that is closely linked to leptin receptor mutation. 21 Since leptin is demonstrated to exert natriuretic action, 22 it may be that the absence of leptin action within the kidney impairs the renal sodium excretion and thus causes hypertension in OZ rats. Although it remains undetermined whether leptin actually plays a substantial role in modulating renal sodium excretion under physiological conditions, it is intriguing to hypothesize the renal effect of leptin in the pathogenesis of hypertension.
Recent studies have been conducted on the mechanisms whereby increased RPP inhibits renal tubular sodium absorption. Cowley et al 10 demonstrated that the elevation of renal interstitial hydrostatic pressure (RIHP) was essential to intact pressure-natriuresis response, and subsequent studies have reported that papillary hemodynamics play an important role in the regulation of RIHP. 10, 23 Much attention has been focused on the role of NO in mediating pressure-natriuresis. Nakamura et al 24 showed that the NO blockade reduced RIHP and impaired pressure-natriuresis. Furthermore, the present study demonstrates that the pressure-natriuresis response is impaired in OZ rats in which medullary NOx levels are reduced (Figure 2 ). In concert, available evidence suggests that renal medullary NO participates in the transmission of RPP to RIHP and the subsequent pressure-natriuresis. 24 Of interest, Majid et Renal cortical and medullary NOx production in lean and obese Zucker rats. NOx levels in obese Zucker rats was markedly reduced in both the cortex and the medulla when compared with that in lean Zucker rats. This suppressed production was partially restored by troglitazone. Furthermore, increased RPP had no effect on cortical NOx levels in either group. In the medulla, however, lean Zucker rats manifested RPP-induced increases in NOx content, whereas in obese Zucker rats, elevated RPP failed to augment NOx levels. Results are meanϮSEM. nϭ7 for each group. *PϽ0.05 vs baseline. Lean indicates lean Zucker rats; Obese, obese Zucker rats.
al 25, 26 have recently demonstrated RPP-dependent alterations in renal cortical and medullary NO activity, using an NO-selective microelectrode. In the present study, we found that elevating RPP increased medullary NOx contents in LZ, but this response was lost in OZ. Furthermore, troglitazone failed to restore the medullary NOx responses or only partially corrected the pressure-natriuresis in OZ rats. Although the source of renal interstitial NOx remains undetermined, the parallel responses of medullary NO activity 26 and NOx to elevated RPP suggest that at least a part of medullary NOx reflects actual NO within the kidney. Furthermore, the reduced basal NOx and impaired NOx responses to elevated RPP may be responsible for the blunted pressure-natriuresis in OZ rats. Thus it is intriguing to assume that the integrity of pressure-natriuresis requires an intact RPP-induced NO activity within the medulla. 26 Of note, Zou and Cowley 27 reported that renal interstitial NO release is greater in the medulla than in the cortex, whereas the present study indicated similar NO release in these zones. These discrepant observations may be related to the differences in the technique used; Zou and Cowley measured the NO levels by the hemoglobin trapping technique, whereas we used the Griess reaction.
Accumulating evidence suggests an effect of insulin resistance on vascular NO activity. 28 -30 Insulin is reported to cause vasodilation by enhancing NO release in several vascular beds, including the renal 31 and forearm vessels. 32 Furthermore, Walker et al 29 found that insulin-mediated dilation of the mesenteric artery was diminished in OZ rats. We have recently demonstrated that insulin-induced dilation of the afferent arteriole is mediated by NO in the isolated perfused hydronephrotic kidney, 31 and this insulin-induced vasodilation is impaired in OZ rats. 30 With the use of a renal microdialysis technique, the present study demonstrates that the renal NOx is markedly diminished in insulin-resistant OZ rats compared with that in LZ rats. To the extent that the medullary NO plays an important role in pressure-natriuresis, 9,23-27 the diminished renal medullary NO production may contribute to the blunted pressure-natriuresis in OZ rats. In concert, these observations lend support to the contention that the insulin resistance is associated with impaired NO production, which could contribute to the development of hypertension. Of note, troglitazone completely corrected the serum insulin level and hypertension but partially ameliorated the renal interstitial NOx or pressure-natriuresis. Thus the reduced renal NO activity in OZ rats is not totally attributable to insulin resistance but may also be related to a genetic background of this rat strain. Alternatively, normalization of blood pressure by troglitazone may be due to direct inhibition of L-type calcium channels of the vascular smooth muscle 33 or modulation of vascular remodeling, 34 both of which may lead to improvement in pressure-natriuresis. Further studies are required to clarify these issues.
In conclusion, the present study demonstrates that obese Zucker rats, characterized by insulin resistance, exhibit impaired pressure-natriuresis and systemic hypertension. Furthermore, correction of insulin sensitivity by troglitazone improves, albeit partially, the blunted pressurenatriuresis response and renal interstitial NOx levels. Thus insulin sensitivity may constitute an important determinant of systemic hypertension and may also contribute at least in part to the integrity of pressure-natriuresis and renal NO production.
